D.E. Shaw & Co
PRNB

D.E. Shaw & Co’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

D.E. Shaw & Co’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,357
Closed -$2.41M – 4341
2020
Q2 		$2.41M Buy
+40,357
New +$2.49M ﹤0.01% 2260

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

D.E. Shaw & Co's PRNB Position: Q3 2020 in Review

D.E. Shaw & Co sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 40,357 shares — an estimated $2.41M sold.

D.E. Shaw & Co first reported a position in PRNB in Q2 2020 and held it in 1 quarter. The position peaked at $2.41M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • D.E. Shaw & Co reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 40,357 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.41M.
  • D.E. Shaw & Co first reported a position in Principia Biopharma Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • D.E. Shaw & Co's Principia Biopharma Inc. Common Stock position peaked at $2.41M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on D.E. Shaw & Co's 13F filing for Q3 2020, filed 16 Nov 2020.